Bayesian reanalysis of the PROfound trial: Olaparib in Asian patients with metastatic castration-resistant prostate cancer

Asian Journal of Urology · Published 2026-07-01 · DOI 10.1016/j.ajur.2026.02.002

Free full text

Authors (12)

Gaku Okumura, Soichiro Yoshida, Kohei Hirose, Shugo Yajima, Wei Chen, Akihiro Hirakawa, Motohiro Fujiwara, Hiroshi Fukushima, Yuki Arita, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Okumura, G., Yoshida, S., Hirose, K., et al. (2026). Bayesian reanalysis of the PROfound trial: Olaparib in Asian patients with metastatic castration-resistant prostate cancer. Asian Journal of Urology. https://doi.org/10.1016/j.ajur.2026.02.002

Related articles